An open-label extension to evaluate the efficacy and safety of rivastigmine capsules in patients with probable vascular dementia
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Rivastigmine (Primary)
- Indications Vascular dementia
- Focus Therapeutic Use
- 16 Nov 2011 Actual patient number added 521 according to ClinicalTrials.gov.
- 02 Jul 2007 Status changed from in progress to completed.
- 16 Nov 2005 New trial record.